FF EAI Robotics Ecosystem 

$1.0300
45
-$0.01-1.44%Friday 19:59

Statistics

Day High
1.07
Day Low
1.05
52W High
2.05
52W Low
0.971
Volume
21,734
Avg. Volume
-
Mkt Cap
20.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 17Expected
Q1 2024
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-26
-17.6
-9.19
-0.79
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-19.53MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AIXC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences is a biopharmaceutical company that competes in the development of therapeutics in areas similar to Qualigen, such as viral diseases, making it a direct competitor.
AMGEN
AMGN
Mkt Cap217.9B
Amgen is a biotech firm focusing on human therapeutics, including treatments for illnesses that Qualigen also targets, positioning it as a competitor.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol Myers Squibb operates in the biopharmaceutical field, developing prescription drugs that overlap with Qualigen's therapeutic areas.
Pfizer
PFE
Mkt Cap158.45B
Pfizer is a global pharmaceutical corporation with a broad product portfolio that includes treatments in areas competing with Qualigen's focus.
Merck
MRK
Mkt Cap356.01B
Merck & Co. is known for its innovative medicines and vaccines, some of which directly compete with Qualigen's product pipeline.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie is a research-based biopharmaceutical company with a strong emphasis on developing innovative therapies, including those in competition with Qualigen.
Regeneron Pharmaceuticals
REGN
Mkt Cap75.69B
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of medicines for serious conditions, competing with Qualigen's therapeutic areas.
Vertex Pharmaceuticals
VRTX
Mkt Cap127.93B
Vertex Pharmaceuticals is focused on creating new possibilities in medicine to cure diseases and improve people's lives, including areas where Qualigen operates.
Novartis
NVS
Mkt Cap268B
Novartis is a global healthcare company that provides solutions to address the evolving needs of patients worldwide, including in sectors where Qualigen is active.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a wide range of medical therapies that compete with Qualigen's developments.

About

Operating under its current name, the First Trust Alerian Disruptive Technology Real Estate ETF (DTRE) was formerly known as the First Trust FTSE EPRA/NAREIT Developed Markets Real Estate Index Fund. Its primary objective is to generally mirror the overall performance—both price appreciation and income generation—of the Alerian Disruptive Technology Real Estate Index, prior to deducting any fund fees and expenses. To achieve this, the fund typically allocates a minimum of 90% of its total investable capital (including any borrowed funds for investment purposes) into the common stocks, Real Estate Investment Trusts (REITs), and depository receipts that collectively form this underlying index.
Show More
CEO
Jiawei Wang
Employees
10
Country
United States
ISIN
US74754R3012
WKN
000A40THA

Listings

0 Comments

Share your thoughts

FAQs

What is FF EAI Robotics Ecosystem stock price today?▼
The current price of AIXC is $1.03 USD — it has decreased by -1.44% in the past 24 hours. Watch FF EAI Robotics Ecosystem stock price performance more closely on the chart.
What is FF EAI Robotics Ecosystem stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange FF EAI Robotics Ecosystem stocks are traded under the ticker AIXC.
What is FF EAI Robotics Ecosystem market cap?▼
Today FF EAI Robotics Ecosystem has the market capitalization of 20.84M
When is the next FF EAI Robotics Ecosystem earnings date?▼
FF EAI Robotics Ecosystem is going to release the next earnings report on November 17, 2026.
What is FF EAI Robotics Ecosystem revenue for the last year?▼
FF EAI Robotics Ecosystem revenue for the last year amounts to 0 USD.
What is FF EAI Robotics Ecosystem net income for the last year?▼
AIXC net income for the last year is -19.53M USD.
How many employees does FF EAI Robotics Ecosystem have?▼
As of November 1, 2026, the company has 10 employees.
In which sector is FF EAI Robotics Ecosystem located?▼
FF EAI Robotics Ecosystem operates in the Technology sector.
When did FF EAI Robotics Ecosystem complete a stock split?▼
FF EAI Robotics Ecosystem has not had any recent stock splits.
Where is FF EAI Robotics Ecosystem headquartered?▼
FF EAI Robotics Ecosystem is headquartered in EL SEGUNDO, United States.